In 2007, the CIN started with 25 principal investigators as cluster applicants, as stipulated in the DFG call for bids. When the CIN cluster was approved further scientists from a range of institutions were incorporated, to make up the 48 'founding members' of the CIN. Since the beginning of 2014 the CIN has consisted of over 80 scientists in total. The membership process involves an application to the steering committee in which the candidate outlines his or her scientific profile and submits a list of publications. The committee's decision is based purely on the scientific excellence of each candidate.
Prof. Dr. Christian la Fougère
Organization: University Hospital Tübingen
Phone number: +49 (0)7071 29-8 65 53
Department: Division for Nuclear Medicine and Clinical Molecular Imaging
Area: CIN Members
Field of Research
Molecular imaging (MI) is paving the way for precision and personalized medicine. We aim to test and to implement new molecular imaging probes for different neurological (e.g. epilepsy) and neurodegenerative diseases (dementia and parkinsonian syndromes) as well as brain tumors, in order to obtain a better characterization of the underlying molecular changes in the brain in vivo. We aim to use those multi-parametric imaging techniques in order to provide an insight in physiological (adaptive) as well as pathophysiological changes in the brain, which might lead to an individualized treatment stratification for our patients in the future.
Molecular imaging techniques using radiolabeled pharmaceuticals and positron-emission-tomography (PET) are increasingly used for the assessment of pathobiochemical and pathophysiological changes in the brain. New generation hybrid PET-MR scanner enable the simultaneous acquisition of molecular (PET) as well as morphological and functional (chemical shifts, flow, diffusion, blood oxygenation and perfusion) changes (MR) in vivo, that might in addition give new insights in the processes of brain plasticity.
la Fougere C*, Zwergal A*, Rominger A, Förster S, Fesl G, Dieterich M, Brandt T, Strupp M, Bartenstein P, Jahn K. Real versus Imagined Locomotion: an intraindividual [18F]-FDG PET - fMRI comparison. Neuroimage 2010;50(4):1589-1598
la Fougere C, Grant S, Kostikov A, Schirrmacher R, Gravel P, Schipper H, Reader A, Evans A, Thiel A. Where in-vivo imaging meets cytoarchitectonics: the relationship between cortical thickness and neuronal density measured with High-Resolution [18F]flumazenil-PET. Neuroimage. 2011;56(3):951-60
Zwergal A*, la Fougère C*, Lorenzl S, Rominger A, Xiong G, Deutschenbaur L, Linn J, Krafczyk S, Dieterich M, Brandt T, Strupp M, Bartenstein P, Jahn J. Postural imbalance and falls in PSP correlate with functional pathology of the thalamus. Neurology. 2011;12(2):101-9
Jansen N, Graute V, Armbruster L, Suchorska B, Lutz J, Eigenbrod S, Cumming P, Bartenstein P, Tonn JC, Kreth FW, la Fougère C. MRI-suspected Low Grade Glioma: is there a need to perform dynamic FET-PET? Eur J Nucl Med Mol Imaging 2012;39(6):1021-9
Jansen N, Suchorska B, Wenter V, Eigenbrod S, Schmid-Tannwald C, Zwergal A, Niyazi M, Drexler M, Bartenstein P, Schnell O, Tonn JC, Thon N, Kreth FW, la Fougère C. Dynamic FET-PET in newly diagnosed astrocytic low grade glioma identifies high risk patients. J Nucl Med. 2014 Feb;55(2):198-203